Immune cell infiltrates in peritoneal metastases from colorectal cancer

Immune cell infiltrates in peritoneal metastases from colorectal cancer

BackgroundThe presence of peritoneal metastases (PMs) in patients with colorectal cancer (CRC) confers a poor prognosis and only a minority of patients will benefit from the available treatment options. In primary CRC tumors, it is well established that a high infiltration of CD8+ effector T cells c...

Full description

Bibliographic Details
Main Authors:	Patrik Sundström, Stephen Hogg, Marianne Quiding Järbrink, Elinor Bexe Lindskog
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Immunology
Subjects:	peritoneal carcinomatosis colorectal cancer T cell PD-1 IFN-γ immune therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1347900/full

Similar Items

Repeat cytoreductive surgery with HIPEC for colorectal peritoneal metastases: a systematic review
by: Mina Sarofim, et al.
Published: (2024-04-01)

Antigen Presenting Cells from Tumor and Colon of Colorectal Cancer Patients Are Distinct in Activation and Functional Status, but Comparably Responsive to Activated T Cells
by: Frank Liang, et al.
Published: (2021-10-01)

Expression of pH-Sensitive GPCRs in Peritoneal Carcinomatosis of Colorectal Cancer—First Results
by: Philipp von Breitenbuch, et al.
Published: (2023-02-01)

Efficacy of Surgical Treatment of Peritoneal Carcinomatosis in Patients with Colorectal Cancer
by: T G Fetsych, et al.
Published: (2016-09-01)

Immune Microenvironment in Sporadic Early-Onset versus Average-Onset Colorectal Cancer
by: Fanny Andric, et al.
Published: (2023-02-01)

Diagnosis of Peritoneal Carcinomatosis of Colorectal Origin Based on an Innovative Fuzzy Logic Approach
by: Valentin Bejan, et al.
Published: (2022-05-01)

Application of Imaging Indicators Based on 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Colorectal Peritoneal Carcinomatosis
by: Chun-Feng Sun, et al.
Published: (2022-05-01)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Summary of Key Clinical Trials
by: Kevin M. Turner, et al.
Published: (2022-06-01)

Intratumoral regulatory T cells from colon cancer patients comprise several activated effector populations
by: Louis Szeponik, et al.
Published: (2021-08-01)

Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival
by: Hamideh Salimzadeh, et al.
Published: (2020-05-01)

Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort study
by: Atuhani Burnett, et al.
Published: (2019-05-01)

Cytoreductive surgery for synchronous and metachronous colorectal peritoneal dissemination: Japanese P classification and peritoneal cancer index
by: Akiyoshi Mizumoto, et al.
Published: (2024-01-01)

5-fluorouracil treatment of patient-derived scaffolds from colorectal cancer reveal clinically critical information
by: Simona Salerno, et al.
Published: (2022-05-01)

Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy
by: Aras Emre Canda, et al.
Published: (2018-03-01)

Predictors of Recurrence of Peritoneal Carcinomatosis among Patients with Colorectal Cancer Following Cytoreductive Surgery alone versus Cytoreductive Surgery Plus HIPEC
by: Waheed Yousry Gareer, et al.
Published: (2022-06-01)

The Diagnostic Usefulness of Ultrasound-Guided Peritoneal Biopsy for the Solitary Peritoneal Thickening of an Unknown Cause Visualized as Only Infiltrated Fat Tissue on a CT Scan
by: Yun Ju Chu, et al.
Published: (2018-04-01)

CT mimics of peritoneal carcinomatosis
by: S Smiti, et al.
Published: (2010-01-01)

CT mimics of peritoneal carcinomatosis
by: Smiti S, et al.
Published: (2010-01-01)

The CEA/PCI ratio is a superior prognosticator than mCOREP for colorectal cancer patients with peritoneal carcinomatosis
by: Phelopatir Anthony, MD, MS, et al.
Published: (2024-06-01)

Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases
by: Raphaëla Carmen Dresen, et al.
Published: (2019-01-01)

Selection Criteria for Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Treatment in Patients with Peritoneal Metastases
by: Aurélie Balmer, et al.
Published: (2022-05-01)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis
by: Seung Jae Roh, et al.
Published: (2020-02-01)

Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases
by: Wim Ceelen, et al.
Published: (2022-08-01)

Clinical Efficacy and Safety of Hyperthermic Intraperitoneal Chemotherapy in Colorectal Cancer Patients at High Risk of Peritoneal Carcinomatosis: A Systematic Review and Meta-Analysis
by: Peng-yue Zhao, et al.
Published: (2020-11-01)

Prognostic Factors of Survival in Patients with Peritoneal Metastasis from Colorectal Cancer
by: Fernando Mendoza-Moreno, et al.
Published: (2022-08-01)

Peritoneal deciduosis mimicking peritoneal Carcinomatosis: A case report
by: João Casanova, et al.
Published: (2021-08-01)

Bowel Obstruction and Perforation as Emergency Presenting Sign of Colorectal Cancer with Peritoneal Carcinomatosis: A Case Report and Review
by: Randy Adiwinata, et al.
Published: (2020-12-01)

Colorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: The experience of a tertiary Asian center
by: Melissa Ching Ching Teo, et al.
Published: (2015-04-01)

The Interaction between Reactive Peritoneal Mesothelial Cells and Tumor Cells via Extracellular Vesicles Facilitates Colorectal Cancer Dissemination
by: Simona Serratì, et al.
Published: (2021-05-01)

Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study
by: Leonardo Solaini, et al.
Published: (2019-03-01)

Adipocytic Glutamine Synthetase Upregulation via Altered Histone Methylation Promotes 5FU Chemoresistance in Peritoneal Carcinomatosis of Colorectal Cancer
by: Xuan Zhang, et al.
Published: (2021-10-01)

Intraabdominal Tuberculosis Cases Presenting with Peritoneal Carcinomatosis
by: Nazlım AKTUĞ DEMİR, et al.
Published: (2020-06-01)

Effect of Intraperitoneal Chemotherapy with Regorafenib on IL-6 and TNF-α Levels and Peritoneal Cytology: Experimental Study in Rats with Colorectal Peritoneal Carcinomatosis
by: Stefanos Bitsianis, et al.
Published: (2023-11-01)

Prognostic value of peritoneal scar-like tissue in patients with peritoneal metastases of ovarian origin presenting for curative-intent cytoreductive surgery
by: Antoine El Asmar, et al.
Published: (2023-08-01)

Amplifying Curcumin’s Antitumor Potential: A Heat-Driven Approach for Colorectal Cancer Treatment
by: Kabagwira J, et al.
Published: (2024-01-01)

THE ROLE OF HIPEC IN PERITONEAL CARCINOMATOSIS DUE TO COLORECTAL CANCER – PROCEDURE, COMPLICATIONS, AND LITERATURE EVIDENCE
by: Iulian Slavu, et al.
Published: (2020-12-01)

Effects of Hyperthermia and Hyperthermic Intraperitoneal Chemoperfusion on the Peritoneal and Tumor Immune Contexture
by: Daryl K. A. Chia, et al.
Published: (2023-08-01)

Neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a feasibility and safety study
by: M. Leimkühler, et al.
Published: (2019-01-01)

GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases
by: Fernando Pereira, et al.
Published: (2022-05-01)

Florid Diffuse Peritoneal Deciduosis Mimicking Peritoneal Carcinomatosis: A Case Report
by: Nurhan Erzurumluoğlu, et al.
Published: (2016-06-01)